Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy). (Q44397625)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2003

Language	Label	Description	Also known as
English	Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy).	scientific article published in April 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy). (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Christopher P Cannon

7

object named as

Christopher P Cannon

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sabina A Murphy

3

object named as

Sabina A Murphy

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Duane S Pinto

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

David P Lorenz

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Susan J Marble

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Peter M DiBattiste

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Laura A Demopoulos

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

C Michael Gibson

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

TIMI Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

976-8, A4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Relation between activated clotting time during angioplasty and abrupt closure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Heparin dosing in patients undergoing coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

In vivo demonstration of an antithrombin effect of abciximab

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900117-6

7 January 2021

Identifiers

10.1016/S0002-9149(03)00117-6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44397625&oldid=2086503133"